Tysabri and Hemianopia homonymous - a phase IV clinical study of FDA data

Summary:

Hemianopia homonymous is reported as a side effect among people who take Tysabri (natalizumab), especially for people who are female, 30-39 old, have been taking the drug for 2 - 5 years also take Gilenya, and have Depression.

The phase IV clinical study analyzes which people have Hemianopia homonymous when taking Tysabri. It is created by eHealthMe based on reports of 220,870 people who have side effects when taking Tysabri from the FDA, and is updated regularly.

What is Tysabri?

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 221,369 Tysabri users. Check the latest studies of Tysabri.

What is Hemianopia homonymous?

Hemianopia homonymous (visual field defect involving either the two right or the two left halves of the visual fields of both eyes) is found to be associated with 162 drugs and 272 conditions by eHealthMe. Check the latest studies of Hemianopia homonymous.

On Jul, 15, 2026

220,870 people reported to have side effects when taking Tysabri.
Among them, 30 people (0.01%) have Hemianopia homonymous.

Could Tysabri cause Hemianopia homonymous?

Among these 30 people:

How long have people been on Tysabri when they have Hemianopia homonymous? *

What is the gender of people who have Hemianopia homonymous when taking Tysabri? *

female: 90 %
male: 10 %

What is the age of people who have Hemianopia homonymous when taking Tysabri? *

What are other drugs people take besides Tysabri? *

Gilenya: 8 people, 26.67%
Wellbutrin: 7 people, 23.33%
Mitoxantrone: 4 people, 13.33%
Zoloft: 2 people, 6.67%
Xanax: 2 people, 6.67%
Sertraline: 2 people, 6.67%
Mirtazapine: 2 people, 6.67%
Lovenox: 2 people, 6.67%
Fluoxetine Hydrochloride: 2 people, 6.67%

What are other side effects people have besides Hemianopia homonymous? *

Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 16 people, 53.33%
Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 9 people, 30.00%
Visual Impairment: 8 people, 26.67%
Swallowing Difficulty: 8 people, 26.67%
Gait Disturbance: 7 people, 23.33%
Speech Impairment (Adult) (inability to speak (adult)): 6 people, 20.00%
Foot Deformity (functional disability of foot): 5 people, 16.67%
Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 5 people, 16.67%
Hypokinesia (decreased bodily movement): 4 people, 13.33%
Disturbance In Attention: 4 people, 13.33%

What are the existing conditions these people have? *

Depression: 10 people, 33.33%
Quadriplegia (a four limb paralysis): 4 people, 13.33%
Disturbance In Attention: 4 people, 13.33%
Haemodynamic Test Abnormal: 3 people, 10.00%
Birth Control: 3 people, 10.00%
Insomnia (sleeplessness): 2 people, 6.67%
Adjustment Disorder With Depressed Mood: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tysabri and have Hemianopia homonymous?

- Check whether Hemianopia homonymous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tysabri:

Tysabri (221,369 reports)

Browse all side effects of Tysabri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hemianopia homonymous:

Hemianopia homonymous (162 drugs)

Browse all the conditions that are associated with Hemianopia homonymous:

Hemianopia homonymous (272 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on natalizumab (the active ingredients of Tysabri) and Tysabri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.